Protective effects of miR-34b and miR-337 against myocardial ischemia/reperfusion injury in rats by liposomal nano-delivery system

Author:

Liu Junyan1,Xing Jingxian1,Li Ya1,Liu Juan1,Tian Miao1,Xu Ze-Sheng1

Affiliation:

1. Second Department of Cardiology, Cangzhou Central Hospital, Cangzhou, 061001, China

Abstract

Although a few microRNAs (miRNAs) are involved in the regulation of myocardial ischemia/reperfusion injury (MI/RI), their exact roles in this process, and the mechanisms involved have not been fully elucidated. This study was carried out to investigate the protective effects of miR-34b and miR-337 against MI/RI. For this purpose, 56 Sprague-Dawley (SD) rats were randomly divided into two groups: sham operation group and myocardial MI/RI group, with 28 rats in each group. Then, a rat model of MI/RI was established. Changes in myocardial tissues of the two groups were determined using hematoxylin-Eosin (H&E) staining. Serum level of myocardial troponin c(TnT) was assayed with ELISA method, while myocardial tissue mRNA expressions of miR in the two groups was determined with qRT-PCR. Results showed that the rat model of MI/RI was successfully established, as was evident in myocardial cell necrosis, disorganized myocardial fibers, interstitial edema, and neutrophil infiltration. There were significant increases in serum troponin content and mRNA expression levels of miR-337 and miR-34b in tissues. In conclusion, the expression levels of miR-337 and miR-34b are increased in myocardial tissues of rats with MI/RI. Thus, miR-337 and miR-34b may be involved in the pathogenesis of MI/RI via regulation of NOX4 and Samd7, respectively. Finally, by using liposomal nanocarrier, the therapeutic effect of miR-337 and miR-34b on MI/RI was investigated.

Publisher

American Scientific Publishers

Subject

General Materials Science

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3